John E. Abele, Director at BOSTON SCIENTIFIC CORP (BSX), sold 50,000 shares at $5.68 ($284K) on 2010-08-04, disclosed to the SEC on 2010-08-06.
Scheduled sale ($284k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BSX | BUY | 2015-08-18 | $1.8M | — | Filing → |
| BSX | SELL | 2010-08-19 | $23K | — | Filing → |
| BSX | SELL | 2010-08-18 | $273K | — | Filing → |